Skip to main content
. 2021 May 10;6(3):100115. doi: 10.1016/j.esmoop.2021.100115

Figure 2.

Figure 2

Survival curves of secondary endpoints.

Kaplan–Meier curves of (A) overall survival (OS), (B) TTF, and (C) progression-free survival (PFS) with hazard ratio (HR) calculated by propensity score analysis using the inverse probability of treatment weighting (IPTW) method.

A/AFA, Afatinib; CI, confidence interval; EGFR-TKI, epidermal growth factor receptor-tyrosine kinase inhibitor; O/OSI, osimertinib.